222 related articles for article (PubMed ID: 26710883)
1. Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria.
Gisslinger H; Jeryczynski G; Gisslinger B; Wölfler A; Burgstaller S; Buxhofer-Ausch V; Schalling M; Krauth MT; Schiefer AI; Kornauth C; Simonitsch-Klupp I; Beham-Schmid C; Müllauer L; Thiele J
Leukemia; 2016 May; 30(5):1126-32. PubMed ID: 26710883
[TBL] [Abstract][Full Text] [Related]
2. The 2014 BCSH criteria and the 2016 WHO criteria for essential thrombocythemia: A comparison in a large-scale cohort.
Ochiai T; Yasuda H; Araki M; Misawa K; Morishita S; Nudejima M; Hironaka Y; Shirane S; Edahiro Y; Gotoh A; Ohsaka A; Komatsu N
Eur J Haematol; 2018 Jun; 100(6):544-549. PubMed ID: 29405428
[TBL] [Abstract][Full Text] [Related]
3. Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia.
Kamiunten A; Shide K; Kameda T; Ito M; Sekine M; Kubuki Y; Hidaka T; Akizuki K; Tahira Y; Toyama T; Kawano N; Marutsuka K; Maeda K; Takeuchi M; Kawano H; Sato S; Ishizaki J; Shimoda H; Yamashita K; Matsuoka H; Shimoda K
Int J Hematol; 2018 Oct; 108(4):411-415. PubMed ID: 29987745
[TBL] [Abstract][Full Text] [Related]
4. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
5. Masked polycythemia vera diagnosed according to WHO and BCSH classification.
Barbui T; Thiele J; Carobbio A; Gisslinger H; Finazzi G; Rumi E; Luigia Randi M; Vannucchi AM; Gisslinger B; Müllauer L; Ruggeri M; Rambaldi A; Tefferi A
Am J Hematol; 2014 Feb; 89(2):199-202. PubMed ID: 24166817
[TBL] [Abstract][Full Text] [Related]
6. Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria.
Rumi E; Boveri E; Bellini M; Pietra D; Ferretti VV; Sant'Antonio E; Cavalloni C; Casetti IC; Roncoroni E; Ciboddo M; Benvenuti P; Landini B; Fugazza E; Troletti D; Astori C; Cazzola M;
Oncotarget; 2017 Nov; 8(60):101735-101744. PubMed ID: 29254200
[TBL] [Abstract][Full Text] [Related]
7. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
[TBL] [Abstract][Full Text] [Related]
8. Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis.
Brousseau M; Parot-Schinkel E; Moles MP; Boyer F; Hunault M; Rousselet MC
Histopathology; 2010 May; 56(6):758-67. PubMed ID: 20546341
[TBL] [Abstract][Full Text] [Related]
9. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.
Barbui T; Thiele J; Passamonti F; Rumi E; Boveri E; Ruggeri M; Rodeghiero F; d'Amore ES; Randi ML; Bertozzi I; Marino F; Vannucchi AM; Antonioli E; Carrai V; Gisslinger H; Buxhofer-Ausch V; Müllauer L; Carobbio A; Gianatti A; Gangat N; Hanson CA; Tefferi A
J Clin Oncol; 2011 Aug; 29(23):3179-84. PubMed ID: 21747083
[TBL] [Abstract][Full Text] [Related]
10. Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.
Barbui T; Thiele J; Vannucchi AM; Tefferi A
Blood Cancer J; 2015 Aug; 5(8):e337. PubMed ID: 26832847
[TBL] [Abstract][Full Text] [Related]
11. Follow-up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): a retrospective clinicopathological study of 120 patients.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Zankovich R; Diehl V
Am J Hematol; 2002 Aug; 70(4):283-91. PubMed ID: 12210809
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.
Michiels JJ
Hematol J; 2004; 5(2):93-102. PubMed ID: 15048058
[TBL] [Abstract][Full Text] [Related]
13. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
[TBL] [Abstract][Full Text] [Related]
14. Value of bone marrow biopsy in the diagnosis of essential thrombocythemia.
Florena AM; Tripodo C; Iannitto E; Porcasi R; Ingrao S; Franco V
Haematologica; 2004 Aug; 89(8):911-9. PubMed ID: 15339673
[TBL] [Abstract][Full Text] [Related]
15. Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia.
Carobbio A; Finazzi G; Thiele J; Kvasnicka HM; Passamonti F; Rumi E; Ruggeri M; Rodeghiero F; Luigia Randi M; Bertozzi I; Vannucchi AM; Antonioli E; Gisslinger H; Buxhofer-Ausch V; Gangat N; Rambaldi A; Tefferi A; Barbui T
Am J Hematol; 2012 Feb; 87(2):203-4. PubMed ID: 22237692
[TBL] [Abstract][Full Text] [Related]
16. The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances.
Barbui T; Thiele J; Gisslinger H; Finazzi G; Vannucchi AM; Tefferi A
Blood Rev; 2016 Nov; 30(6):453-459. PubMed ID: 27341755
[TBL] [Abstract][Full Text] [Related]
17. Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification.
Thiele J; Kvasnicka HM; Müllauer L; Buxhofer-Ausch V; Gisslinger B; Gisslinger H
Blood; 2011 May; 117(21):5710-8. PubMed ID: 21447832
[TBL] [Abstract][Full Text] [Related]
18. The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia.
Mudireddy M; Barraco D; Hanson CA; Pardanani A; Gangat N; Tefferi A
Am J Hematol; 2017 May; 92(5):454-459. PubMed ID: 28211153
[TBL] [Abstract][Full Text] [Related]
19. The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera.
Kvasnicka HM; Thiele J
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):362-71. PubMed ID: 16810612
[TBL] [Abstract][Full Text] [Related]
20. [Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome].
Brière J
Bull Acad Natl Med; 2007 Mar; 191(3):535-48. PubMed ID: 18072652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
